PFENEX INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout
August 11, 2020 13:04 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Pfenex Inc. (“Pfenex”) (NYSE American: PFNX) regarding possible breaches of...
LGND LOSS ALERT: Rosen Law Firm Reminds Ligand Pharmaceuticals Incorporated Investors of Important January 17 Deadline in Class Action Filed by Firm - LGND
January 05, 2017 13:52 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 05, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Ligand Pharmaceuticals Incorporated securities (NASDAQ:LGND) from November 9,...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Ligand Pharmaceuticals Incorporated - LGND
December 21, 2016 13:01 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 21, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Ligand Pharmaceuticals...
LIGAND PHARMACEUTICALS INVESTOR REMINDER: Hagens Berman Reminds Ligand Pharmaceuticals Investors of Securities Class Action Lead Plaintiff Deadline
December 14, 2016 09:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 14, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) of the January 17, 2017 Lead Plaintiff deadline. ...
LIGAND PHARMACEUTICALS INVESTOR ALERT: Hagens Berman Alerts Ligand Pharmaceuticals Investors to Accounting Restatements, Securities Class Action, and Lead Plaintiff Deadline
November 23, 2016 09:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Nov. 23, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) to the securities class action filed in the U.S....